Discovery of 2-((4-(phenylsulfonyl)piperazin-1-yl)methyl)-1H-indole derivative B9, an anti-inflammatory agent targeting acute and chronic inflammation for the treatment of acute lung injury and diabetic kidney disease
Discovery of 2-((4-(phenylsulfonyl)piperazin-1-yl)methyl)-1H-indole derivative B9, an anti-inflammatory agent targeting acute and chronic inflammation for the treatment of acute lung injury and diabetic kidney disease. // European Journal of Medicinal Chemistry. – URL: https://www.sciencedirect.com/science/article/pii/S0223523426009323?dgcid=rss_sd_all
Discovery of 2-((4-(phenylsulfonyl)piperazin-1-yl)methyl)-1H-indole derivative B9, an anti-inflammatory agent targeting acute and chronic inflammation for the treatment of acute lung injury and diabetic kidney disease. European Journal of Medicinal Chemistry. https://www.sciencedirect.com/science/article/pii/S0223523426009323?dgcid=rss_sd_all
“Discovery of 2-((4-(phenylsulfonyl)piperazin-1-yl)methyl)-1H-indole derivative B9, an anti-inflammatory agent targeting acute and chronic inflammation for the treatment of acute lung injury and diabetic kidney disease.” European Journal of Medicinal Chemistry.
@article{article74077,
title = {Discovery of 2-((4-(phenylsulfonyl)piperazin-1-yl)methyl)-1H-indole derivative B9, an anti-inflammatory agent targeting acute and chronic inflammation for the treatment of acute lung injury and diabetic kidney disease},
journal = {European Journal of Medicinal Chemistry},
url = {https://www.sciencedirect.com/science/article/pii/S0223523426009323?dgcid=rss_sd_all}
}
ABSTRACT Singlet oxygen ( 1 O 2 ) is increasingly recognized as a key reactive species in advanced oxidation processes (AOPs) due to its long lifetime, wide pH tolerance, and selective oxidation behaviours toward electron‑rich organic...
ABSTRACT The Truce–Smiles rearrangement (TSR) is a versatile synthetic strategy for carbon–carbon bond formation without the need of metal catalysis. The key step is formation of spiro‐Meisenheimer complex which typically undergoes the...